Heron Therapeutics: Funding, Investors & Team (Oct 2026)
Heron Therapeutics is a specialized pharmaceutical company creating drug products with the help of its Biochronomer polymer-based drug delivery platform. The company's primary product in development, APF530, aims to prevent acute chemotherapy-induced nausea and vomiting for patients receiving both moderately and highly emetogenic chemotherapy, as well as to prevent delayed nausea and vomiting for patients undergoing moderately emetogenic chemotherapy. APF530 includes granisetron, a 5-HT3 antagonist, in Heron's innovative Biochronomer drug delivery system, which allows for sustained therapeutic levels over five days with just one subcutaneous injection.
Heron Therapeutics has raised $252M across 3 funding rounds on record, the most recent an undisclosed round of $145M announced in Aug 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Heron Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Heron Therapeutics Funding Rounds
Heron Therapeutics raised $76.5M in a Post-IPO Equity announced in Aug 2022.
11 months later, an undisclosed round of $30.0M was announced in Jul 2023.
2.1 years later, an undisclosed round of $145M was announced in Aug 2025.
Heron Therapeutics Founders and Leadership Team
Contact details for the Heron Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Heron Therapeutics Funding Compared to Other Biotechnology Startups
Heron Therapeutics' latest round of $145M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Heron Therapeutics in Biotechnology and Redwood City
Companies Similar to Heron Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Heron Therapeutics Funding FAQs
What does Heron Therapeutics do?
Heron Therapeutics is a specialized pharmaceutical company creating drug products with the help of its Biochronomer polymer-based drug delivery platform. The company's primary product in development, APF530, aims to prevent acute chemotherapy-induced nausea and vomiting for patients receiving both moderately and highly emetogenic chemotherapy, as well as to prevent delayed nausea and vomiting for patients undergoing moderately emetogenic chemotherapy. APF530 includes granisetron, a 5-HT3 antagonist, in Heron's innovative Biochronomer drug delivery system, which allows for sustained therapeutic levels over five days with just one subcutaneous injection.
How much funding has Heron Therapeutics raised?
Heron Therapeutics has raised $252M across 3 rounds on record. The most recent is an undisclosed round of $145M announced in Aug 2025.
When did Heron Therapeutics last raise funding?
Heron Therapeutics' most recent funding round on record is an undisclosed round of $145M, announced in Aug 2025.
Who is the CEO of Heron Therapeutics?
Barry Quart is listed as CEO at Heron Therapeutics.
Where is Heron Therapeutics headquartered?
Heron Therapeutics is based in Redwood City, California, United States.
How many employees does Heron Therapeutics have?
Heron Therapeutics is in the 101-250 employee band.
How does Heron Therapeutics' funding compare to other Biotechnology startups?
Heron Therapeutics' latest round of $145M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Heron Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Heron Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.